Akums Drugs & Pharmaceuticals Ltd Share Price
As of 22 Sept 2026, Akums Drugs & Pharmaceuticals Ltd share price is ₹821.25. The stock opened at ₹821.25 and had closed at ₹783.95 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹410.10 and a high of ₹830.00. In terms of performance, Akums Drugs & Pharmaceuticals Ltd share price has increased by 75.56% over the past six months and has increased by 74.51% over the last year.
AKUMS Stock Price Chart
Akums Drugs & Pharmaceuticals Ltd Overview
About AKUMS
Akums Drugs & Pharmaceuticals is engaged in contract manufacturing which involves manufacturing of pharmaceutical formulations and specializes in developing new formulations, undertaking bio equivalence studies, clinical trials, obtaining Drug Controller General of India's (DCGI) approval for manufacturing and marketing new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Company's own technology to its customers under their brand names.(Source : AR-PDF:202603-01 Pg No:223)
Akums Drugs & Pharmaceuticals Ltd Historical Performance
Akums Drugs & Pharmaceuticals Ltd Fundamentals
Akums Drugs & Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,461.71 | 1,435.97 | 1,538.24 | 1,382.98 | 1,220.54 |
| EBITDA | 203.91 | 262.70 | -51.93 | 193.50 | -303.57 |
| Net Profit | 111.64 | 161.00 | -165.45 | 125.43 | -381.78 |
| EPS | 7.29 | 10.76 | -11.56 | 8.77 | -53.33 |
Akums Drugs & Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 774.22 |
| Resistance 1 (R1) | 791.72 |
| Pivot Point | 781.98 |
Akums Drugs & Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 03-Jul-2026 | 14-May-2026 | 03-Jul-2026 | Final | ₹1.00 |
| 03-Jul-2026 | 14-May-2026 | 03-Jul-2026 | Special | ₹2.00 |
AKUMS Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| SANJEEV JAIN | Managing Director |
| SANDEEP JAIN | Managing Director |
| Sanjay Sinha | Whole-time Directorector |
Akums Drugs & Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Akums Drugs & Pharmaceuticals Ltd today is ₹821.25 on NSE and ₹821.25 on BSE.
- The 52-week high of Akums Drugs & Pharmaceuticals Ltd is ₹830.00, while the 52-week low is ₹410.10.
- The current market capitalisation of Akums Drugs & Pharmaceuticals Ltd is approximately ₹12,926 crore.
- The P/E (Price-to-Earnings) ratio of Akums Drugs & Pharmaceuticals Ltd is 22.67. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Akums Drugs & Pharmaceuticals Ltd is 2.34. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Akums Drugs & Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AKUMS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Akums Drugs & Pharmaceuticals Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Akums Drugs & Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.26% promoters, -7.86% FIIs, 13.44% DIIs, and 5.57% public shareholders.

